(9:40 9:50) (9:50 10:30) O-01 1 2 2 2 2 2 2 2 2 2 3 3 4 4 1 2 3 4 O-02 15-deoxy-Δ 12,14 -PGJ 2 Heme oxygenase-1(ho-1) 1 2 3 3 3 3 3 3 1 1 5 4 3 2 3 4 5 O-03 C hepcidin 1 1 1 1 1 1 1 1 1 2 2 2 2 1 2 O-04 1 2 2 3 4 5 1 2 3 4 5 (10:30 12:00) -01-02 Nrf2 H + K + ATPase 1 1 1 1 1 1 1 1 1 1 2 1 1 2
-03 1 1 1 1 2 1 2-04 -05 Ethanol Preconditioning (EPC) enos(cgrp) 1 Korthuis RJ 2 3 3 3 4 5 1 1 2 Medical Pharmacology and Physiology University of Missouri-Columbia 3 4 5 (12:30 13:30) (13:50 14:10) (14:10 14:50) O-05 SEp22 DNA O-06 N octarepeat 1,3 1,3 1 1 2,3 1 1 2 3 COE
O-07 1 2,3 4 4 5 2,7 2 1 1 2 3 SORST 4 5 7 O-08 E -10 ph 1 1 1 1 1 1 2 1 2 ( ) (14:50 15:30) O-09 1,2 1 2 1 2 O-10 O-11 O-12 FPP(Fermented Papaya Preparation) 1 1 Francesco Marotta 2 Eitan Fibach 3 Elizer Rachmilewitz 3 1 2 Hepato-Gastroenterology Dept., S. Giuseppo Hosp., Milano, Italy 3 Hematology Dept., Hadassah University Hosp., Jerusalem, Israel (15:30 17:30) S-01 S-02 S-03 DNA
S-04 (17:40 19:00) 17:40 18:20 18:20 19:00 (19:20 )
(9:30 10:10) O-13 WBN/Kob 1 2 1 2 O-14 SOD1 1 1 1 2,3 1 1 2 3 ( ) O-15 O-16 NADPH (10:10 10:40) O-17 Humanin 1 1 2 2 2 2 3 1 2 3 O-18 1 2 3 3 4,5 2 T.L. Salunga 2 2 6 7 1 1 2 3 4 21th COE 5 (1) 6 7 O-19 1 2 3 1 1 2 3
(10:40 11:10) O-20 RIBS Okayama JST CREST O-21 ( ) Z-H. Chen 1 1 1 2 2,3 1 1 2 3 O-22 ( ) Z-H. Chen 1 1 1 2 2,3 1 1 2 3 (11:10 12:00) (12:10 13:10) P&G SK-II ROS (13:20 14:00) ESRI OMRI
NO (14:00 14:30) O-23 LPS NO 8-1 2 2 1 1 ( ) 2 O-24 NO tight junction 1,2 1 1,2 1 2 1 2 O-25 1 1 1 1 1 2 1 2 (14:30 15:00) O-26dichlorofluorescin monochlorofluorescein 1 1 1 1 2 3 1 2 3 O-27 DPAX 1 2 2 2 1 1 2 O-28 1 2 1 1 2 DNA (15:00 15:30) O-29 p53 DNA 1 2 3 4 1 2 4 3 O-30 DNA 1 Than Tin Aung 1 1 Dutta Khokon Kumar 1 1 1 1 Janice Onuki 1 2 2 3 4 1 1 2 3 4
O-31 DNA ESR (15:30 16:10) O-32 N-diethylnitrosamine(DEN) O-33 ADP/ /NADPH HPLC-ESR-MS 1 2 1 1 2 O-34 OH 1 1 2 1 2 O-35 1 1 1 2 3 4 1 2 3 4 ESR (16:10 16:40) O-36 ESR CYPMPO 1 2 2 2 2 3 3 4 5 6 1 2 3 4 5 6 /OMRF O-37 TEMPO O-38 ESR (16:40)
17:40 19:00 P-01 1 3 1 1 1 2 1 2 3 P-02 OLETF UCP2 NO/cGMP 1 2 3 3 3 1 1 2 3 P-03 MAPK P-04 hydroperoxide 1 2 1 1 1 1 2 1 1 2 P-05 (SDR) 1 1 1 1 2 3 1 1 2 3 P-06 1,2 1 3 1 3 1 1 2 DC 3 P-07 Th1/Th2 1 2 1 2 1 1 2 P-08 Griseofulvin aminolevulinic acid-based photodynamic therapy (ALA-PDT)
P-09 p- 1,2 1,3 1 2 1,4 1 2 3 4 NICHe P-10 1 2 2 1 1 2 P-11 1 1,2 1 1 1 2 1 2 P-12 1 1 2 3 4 5 1 1 2 3 4 5 P-13 1,2 1,3 1,2 1 2 JST CREST 3 JST P-14 MRI 1 1 2 2 1 1 2 P-15 P-16 Synergistic effect and antioxidant activity of anthocyanins at different ph M. Mamunur Rahman 1, Takashi Ichiyanagi 1, Yoshihiko Hatano 1, Seiichi Matsugo 2, Tetsuya Konishi 1 1 Niigata Univ. of Pharm. & Appl. Life Sciences, Niigata, 2 Yamanashi University, Yamanashi, Japan P-17 P-18 1 1 2 3 1 1 2 3
P-19 Castanospermum australe DNA 1 2 1 2 P-20 1 1 1 1 1 1 2 1 2 P-21 4-1,2,3 1,3 4 3 Sushma Manda 1 2 5 5 4 4 3 1 1,6 1 1 2 3 SORST 4 5 6 P-22 1 1 1 2 1 1 2 C60 P-23 Mn in vitro P-24 P-25 P-26 P-27 TGF β 1 1 1 2 1 1 1 1 1 2 P-28 EC-SOD TNF α
P-29 HL-60 1,2 1 2 1 2 P-30 2,4,6 P-31 X 1 2 1 1 Peng G. Wang 3 4 1 1 2 3 Depts. Biochem. Chem., The Ohio State Univ. 4 DNA P-32 DNA dihydropyrazine radical species 1 1 2 3 1 2 3 P-33 C 70 DNA 1,2 2 1,2,3 1,2,3 1 1 2 4 4 3 5 1,6 1 2 1 1 2 SORST 3 4 5 6 P-34 P-35 DNA P-36 8-OHdG 1,2 1 1 1 2 NO P-37 inos DNA 1 2 3 2 1 3 1 1 2
P-38 inos DNA 1,4 1 2 1 1 El-Karef Amro 3 3 1 1 2 3 4 DC P-39 DNA 1 2 3 1 1 2 3 P-40 EB DNA 1 3 2 4 4 4 4 2 1 2 3 4 P-41 DNA 1 1 2 1 1 1 2 2 1 1 2 P-42 inos NO 1 2 2 2 2 3 4 5 6 1 2 3 4 5 6 ESR P-43 ESR 1 1 2 1 2 P-44 1,2,3 1,2 2 1,2,3 3 1 4 1,5 2 1 1 2 SORST 3 4 5 P-45 Ketprofen 1 1 1 2 2 1 1 2 P-46 ESR 2,3 1 1 1 1 2 3
P-47 P-48